HealthDay News — Intradetrusor injection of onabotulinumtoxin A is safe and effective for bladder chemodenervation in overactive bladder, with new approaches being developed to increase toxin ...

MUNICH — For patients being treated for neurogenic detrusor overactivity with repeated injections of onabotulinumtoxinA (Botox), antibiotics for asymptomatic bacteriuria might not be necessary, new ...

WINSTON-SALEM – URO-1, a medical device startup company in Winston-Salem, has received approval from the U.S. Food and Drug Administration to begin marketing its first product, a new system using ...

Repeated injections of botulinum toxin type A (BoNTA) are safe and effective for the medium-term management of refractory overactive bladder (OAB) and idiopathic detrusor overactivity (IDO), according ...

Washington: A recent research has found that Botox (a bladder injection of botulinum toxin) could help in controlling bladder incontinence, after the first and second-line therapies proved inadequate.

Patients with NGB who have refractory detrusor overactivity may benefit from minimally invasive treatment. Refractory detrusor overactivity is marked by persistent urgency, frequency, and incontinence ...

Medically reviewed by Maria M. LoTempio, MD Key Takeaways Botox can cause temporary redness, swelling, tenderness, or bruising at the injection site.You may get flu-like symptoms like fever, body ...

WINSTON-SALEM, N.C., May 15, 2019 /PRNewswire/ -- URO-1, Inc., an emerging company that develops solutions for office procedures in urology and urogynecology today announced the issuance of US Patent, ...